[Double blind study of tiapride in neoplasia-related pains (author's transl)].
The antalgic effects of tiapride used by intravenous way have been evaluated in a randomized study on 30 patients with neoplasia-related pains. We noticed a partial or a complete positive response in 60 % of the cases when tiapride is given at a dose of 300 mg/day. The average efficient period was about four hours. Tolerance was good.
D001549:Benzamides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D011897:Random Allocation; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use*
D001549:Benzamides; D013976:Tiapamil Hydrochloride
Etude en double insu du tiapride dans les algies en carcinologie.